Long-Lasting Efficacy of Radio Electric Asymmetric Conveyer Neuromodulation Treatment on Functional Dysmetria, an Adaptive Motor Behavior.
endogenous bioelectric activity
epigenetic
functional dysmetria
neurobiological modulation
neuromodulation
neuroplasticity
neurostimulation
neurotransmission
radio electric asymmetric conveyor
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
accepted:
08
06
2022
entrez:
16
6
2022
pubmed:
17
6
2022
medline:
17
6
2022
Statut:
epublish
Résumé
Background Fluctuating asymmetry (FA) is widely defined as the deviation from perfect bilateral symmetry and is considered an epigenetic measure of environmental stress. Rinaldi and Fontani hypothesized that the FA morpho-functional changes originate from an adaptive motor behavior determined by functional alterations in the cerebellum and neural circuits, not caused by a lesion, but induced by environmental stress. They called this phenomenon functional dysmetria (FD). On this premise, they developed the radio electric asymmetric conveyer (REAC) technology, a neuromodulation technology aimed at optimizing the best neuro-psycho-motor strategies in relation to environmental interaction. Aims Previous studies showed that specific REAC neuro postural optimization (NPO) treatment can induce stable FD recovery. This study aimed to verify the duration of the NPO effect in inducing the stable FD recovery over time. Materials and methods Data were retrospectively collected from a population of 29,794 subjects who underwent a specific semiological FD assessment and received the NPO treatment, regardless of the pathology referred. Results The analysis of the data collected by the various participants in the study led us to ascertain the disappearance of FD in 100% of the cases treated, with a stability of the result detected up to 18 years after the single administration of the REAC NPO treatment. Conclusions The REAC NPO neurobiological modulation treatment consisting of a single administration surprisingly maintains a very long efficacy in the correction of FD. This effect can be explained as the long-lasting capacity of the NPO treatment to induce greater functional efficiency of the brain dynamics as proven in previous studies.
Identifiants
pubmed: 35706441
doi: 10.7759/cureus.25768
pmc: PMC9187162
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e25768Informations de copyright
Copyright © 2022, Fontani et al.
Déclaration de conflit d'intérêts
SR and VF are the authors of the REAC patent.. AR and CR are daughters of SR and VF.
Références
ACS Biomater Sci Eng. 2020 Dec 14;6(12):6680-6689
pubmed: 33320620
Horm Behav. 2003 Jan;43(1):2-15
pubmed: 12614627
Front Neurol. 2021 Mar 09;12:635259
pubmed: 33767662
Mech Dev. 2017 Apr;144(Pt A):92-101
pubmed: 27913119
Neuropsychiatr Dis Treat. 2019 Feb 13;15:469-480
pubmed: 30858704
Int J Gen Med. 2011;4:681-6
pubmed: 22069368
Indian J Med Res. 2008 Sep;128(3):254-61
pubmed: 19052335
Ther Clin Risk Manag. 2012;8:73-8
pubmed: 22368448
Cerebellum. 2017 Apr;16(2):552-576
pubmed: 27485952
Coll Antropol. 2011 Dec;35(4):1001-5
pubmed: 22397230
Acta Biomater. 2015 Sep;24:12-23
pubmed: 26162587
Sci Rep. 2014 Jul 11;4:5668
pubmed: 25011544
Biol Rev Camb Philos Soc. 1990 May;65(2):131-45
pubmed: 2190634
Ital J Orthop Traumatol. 1988 Dec;14(4):483-91
pubmed: 3267683
J Neuropsychiatry Clin Neurosci. 2004 Summer;16(3):367-78
pubmed: 15377747
Health Qual Life Outcomes. 2011 Jul 19;9:54
pubmed: 21771304
Psychiatry. 2004 Winter;67(4):412-5
pubmed: 15801383
J Alzheimers Dis. 2013;36(2):297-302
pubmed: 23603397
J Alzheimers Dis. 2014;42(1):325-32
pubmed: 24898637
Patient Prefer Adherence. 2012;6:195-9
pubmed: 22536055
Front Hum Neurosci. 2021 Jul 07;15:681904
pubmed: 34305551
Dev Psychopathol. 2011 Nov;23(4):975-99
pubmed: 22018077
Neuron. 2017 Jun 7;94(5):1033-1039
pubmed: 28595047
Neuropsychiatr Dis Treat. 2012;8:149-54
pubmed: 22536071
Am J Phys Anthropol. 2007 Apr;132(4):520-34
pubmed: 17243154
Proc Biol Sci. 1997 Jun 22;264(1383):823-9
pubmed: 9265189
Cerebellum. 2020 Feb;19(1):102-125
pubmed: 31522332
Psychoneuroendocrinology. 2018 Jun;92:41-49
pubmed: 29625374
J Neuroeng Rehabil. 2009 Apr 13;6:10
pubmed: 19364396
Neuropsychiatr Dis Treat. 2011;7:649-54
pubmed: 22090800
Neuropsychiatr Dis Treat. 2011;7:449-55
pubmed: 21857785